Clinical Trials Logo

Filter by:
NCT ID: NCT06416761 Recruiting - Hypertension Clinical Trials

Genetics in the Progression of Nephropathies

Start date: May 19, 2006
Phase:
Study type: Observational

This study evaluates the role of genetic in the development and progression of different nephropaties with particular attention to: - AKI - CKD - Hypertension - ADPKD - CKD-MBD - Patients with decompensated heart failure undergoing either medical or surgery therapy - Patients with hematologic cancer exposed to chemotherapeutic agents or undergoing allogeneic bone marrow transplantation - glomerular diseases

NCT ID: NCT06416735 Completed - Clinical trials for Genetic Hypertension

Natriuretic Effect of Amiloride in Relation to the Alpha Adducin Gene (ADD-AMI) RS4961 Variant

ADD-AMI
Start date: September 28, 2018
Phase: Phase 3
Study type: Interventional

The study is a non-pharmacological interventional, single-center, national, non-randomised, comparative and open label.

NCT ID: NCT06416215 Recruiting - Obesity Clinical Trials

Promoting Positive Mental Health for Sustainable Eating Behaviors

PROMISE
Start date: January 30, 2024
Phase: N/A
Study type: Interventional

The main aim of the present study is to assess the effects and the effectiveness of a psychological intervention based on the principles of well-being therapy (WBT) in promoting weight-loss, sustainable and healthy eating behaviors and an optimal psychological functioning in patients with obesity.

NCT ID: NCT06415812 Recruiting - Clinical trials for Personality Disorders

Evolutionary Systems Therapy for Personality Pathology

ESTP
Start date: October 2, 2023
Phase: N/A
Study type: Interventional

Evolutionary Systems Therapy is a new form of therapy that has been previously tested in a randomized controlled trial and in a few cases of patients diagnosed with Cluster A personality disorders. The objective of the present study is to investigate the feasibility and preliminary efficacy of Evolutionary Systems Therapy in all forms of personality disorders. The study includes three project actions: (i) a case series on adolescents with personality disorders; (ii) a case series on young adults with personality disorders; (iii) an ecological momentary assessment study to confirm the conceptualization model on all the patients.

NCT ID: NCT06414720 Recruiting - Endometriosis Clinical Trials

Salivary microRNA in Endometriosis: Correlation With Response to Progestin Therapy

ENDOmiRNA
Start date: April 22, 2024
Phase:
Study type: Observational

This study aims to analyze the salivary miRNA specific for patients diagnosed with endometriosis, specifically evaluating the miRNA profile of patients who respond versus those who do not respond to progestin therapy. Ninety patients attending the Chronic Pelvic Pain Clinic will be recruited, and they will be asked to provide a saliva sample before starting medical therapy. The response to the therapy will be evaluated after 4 months from the beginning of the therapy itself.

NCT ID: NCT06414252 Completed - Clinical trials for Hereditary Angioedema

Social Evaluated Cold Pressor Test in Hereditary Angioedema Patients

FROSEN
Start date: May 15, 2023
Phase:
Study type: Observational

This study aims to evaluate the differences in objective and subjective stress responses between patients with hereditary angioedema and healthy individuals to a stress-induced challenge like socially-evaluated cold pressure test. The study also investigates the role of psychological variables in influencing the stress response.

NCT ID: NCT06414044 Recruiting - Migraine Clinical Trials

Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients

STAR
Start date: May 9, 2024
Phase:
Study type: Observational

The purpose of this prospective and multicentric study is to evaluate the effectiveness and tolerability of atogepant as preventive migraine treatment in a cohort of episodic or chronic migraine patients.

NCT ID: NCT06413823 Recruiting - Clinical trials for Cardiovascular Disease

Prevention and Treatment of Cardiovascular Disease

VPC
Start date: May 9, 2024
Phase:
Study type: Observational

In view of the close interrelationship between the various organs and systems of the body, which cannot be examined in a parceled fashion but rather as an integrated system, this study aims to consider the potential risks associated with cardiovascular disease. By identifying additional, often underestimated, altered functions that may affect the patient's quality of life and interfere with the performance of daily activities, this research study aims to evaluate the patient's functioning in an integrated manner to achieve a holistic view of the health and well-being of the patient and caregiver.

NCT ID: NCT06413706 Not yet recruiting - Glioma Clinical Trials

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Start date: June 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to measure the benefit of adding abemaciclib to the chemotherapy, temozolomide, for newly diagnosed high-grade glioma following radiotherapy. Your participation could last approximately 11 months and possibly longer depending upon how you and your tumor respond.

NCT ID: NCT06413459 Recruiting - Clinical trials for Non-Tuberculous Mycobacterial Pneumonia

Identification of New Biological Markers for the Progression of Mycobacterium Abscessus-induced Lung Disease in Cystic Fibrosis

BioMol-MA
Start date: April 8, 2021
Phase:
Study type: Observational

In this project the investigators aim to identify new biological markers by characterizing the response/inflammation associated with the development and progression of M. abscessus lung disease in patients suffering from cystic fibrosis with the aim of increasing current knowledge available on the development and progression of lung disease.